The Europe Magnetoencephalography Market would witness market growth of 4.9% CAGR during the forecast period (2022-2028).
MEG scanners have shown to be one of the most valuable pieces of equipment for researching a wide variety of neurological disorders and conditions, including epilepsy, brain tumors, feelings, and the way one experiences pain. The Magnetoencephalography (MEG) technique makes use of the fact that neuromagnetic impulses are not altered when they travel through the skull and scalp. Even though the technology has been available for decades, there has been a recent surge in interest in scanners because of computer power and hardware developments.
MEG scanners have shown to be one of the most valuable pieces of equipment for researching a wide variety of neurological disorders and conditions, including epilepsy, brain tumors, feelings, and the way one experiences pain. The Magnetoencephalography (MEG) technique uses the fact that neuromagnetic impulses are not altered when they travel through the skull and scalp.
Even though the technology has been available for decades, there has been a recent surge in interest in scanners because of computer power and hardware developments. In addition, the increasing number of research and development activities is anticipated to be one of the primary factors that will drive growth in the market for magnetoencephalography scanners throughout the projected period.
The 'Medical Informatics' funding scheme, which the German government offers as part of the Health Research Framework Program, provides an opportunity to improve the exchange of data across various institutions and locations. The hope is that more rapid diagnosis and treatment will lead to cost reductions and improved individual access to care that is both quicker and more accurate. These measures taken by regional governments to boost the adoption of cutting-edge medical technology would help the development of the market in the Europe area.
The Germany market dominated the Europe Magnetoencephalography Market by Country in 2021; thereby, achieving a market value of $24,285.3 Thousands by 2028. The UK market is exhibiting a CAGR of 4% during (2022 - 2028). Additionally, The France market would experience a CAGR of 5.7% during (2022 - 2028).
Based on Application, the market is segmented into Clinical and Research. Based on Clinical Type, the market is segmented into Epilepsy, Dementia, Autism, Stroke, Multiple Sclerosis, Schizophrenia and Others. Based on End-use, the market is segmented into Hospitals, Academic & Research Institutes and Imaging centres. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Compumedics Limited, Ricoh Company, Ltd, FieldLine, Inc., MEGIN OY, CTF MEG Neuro Innovations, Inc. and Cerca Magnetics Limited
MEG scanners have shown to be one of the most valuable pieces of equipment for researching a wide variety of neurological disorders and conditions, including epilepsy, brain tumors, feelings, and the way one experiences pain. The Magnetoencephalography (MEG) technique makes use of the fact that neuromagnetic impulses are not altered when they travel through the skull and scalp. Even though the technology has been available for decades, there has been a recent surge in interest in scanners because of computer power and hardware developments.
MEG scanners have shown to be one of the most valuable pieces of equipment for researching a wide variety of neurological disorders and conditions, including epilepsy, brain tumors, feelings, and the way one experiences pain. The Magnetoencephalography (MEG) technique uses the fact that neuromagnetic impulses are not altered when they travel through the skull and scalp.
Even though the technology has been available for decades, there has been a recent surge in interest in scanners because of computer power and hardware developments. In addition, the increasing number of research and development activities is anticipated to be one of the primary factors that will drive growth in the market for magnetoencephalography scanners throughout the projected period.
The 'Medical Informatics' funding scheme, which the German government offers as part of the Health Research Framework Program, provides an opportunity to improve the exchange of data across various institutions and locations. The hope is that more rapid diagnosis and treatment will lead to cost reductions and improved individual access to care that is both quicker and more accurate. These measures taken by regional governments to boost the adoption of cutting-edge medical technology would help the development of the market in the Europe area.
The Germany market dominated the Europe Magnetoencephalography Market by Country in 2021; thereby, achieving a market value of $24,285.3 Thousands by 2028. The UK market is exhibiting a CAGR of 4% during (2022 - 2028). Additionally, The France market would experience a CAGR of 5.7% during (2022 - 2028).
Based on Application, the market is segmented into Clinical and Research. Based on Clinical Type, the market is segmented into Epilepsy, Dementia, Autism, Stroke, Multiple Sclerosis, Schizophrenia and Others. Based on End-use, the market is segmented into Hospitals, Academic & Research Institutes and Imaging centres. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Compumedics Limited, Ricoh Company, Ltd, FieldLine, Inc., MEGIN OY, CTF MEG Neuro Innovations, Inc. and Cerca Magnetics Limited
Scope of the Study
Market Segments Covered in the Report:
By Application
- Clinical
- Epilepsy
- Dementia
- Autism
- Stroke
- Multiple Sclerosis
- Schizophrenia
- Others
- Research
By End-use
- Hospitals
- Academic & Research Institutes
- Imaging centres
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Compumedics Limited
- Ricoh Company, Ltd
- FieldLine, Inc
- MEGIN OY
- CTF MEG Neuro Innovations, Inc
- Cerca Magnetics Limited
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Magnetoencephalography Market, by Application
1.4.2 Europe Magnetoencephalography Market, by End-use
1.4.3 Europe Magnetoencephalography Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Magnetoencephalography Market by Application
3.1 Europe Clinical Market by Country
3.2 Europe Magnetoencephalography Market by Clinical Type
3.2.1 Europe Epilepsy Market by Country
3.2.2 Europe Dementia Market by Country
3.2.3 Europe Autism Market by Country
3.2.4 Europe Stroke Market by Country
3.2.5 Europe Multiple Sclerosis Market by Country
3.2.6 Europe Schizophrenia Market by Country
3.2.7 Europe Others Market by Country
3.3 Europe Research Market by Country
Chapter 4. Europe Magnetoencephalography Market by End-use
4.1 Europe Hospitals Market by Country
4.2 Europe Academic & Research Institutes Market by Country
4.3 Europe Imaging centres Market by Country
Chapter 5. Europe Magnetoencephalography Market by Country
5.1 Germany Magnetoencephalography Market
5.1.1 Germany Magnetoencephalography Market by Application
5.1.1.1 Germany Magnetoencephalography Market by Clinical Type
5.1.2 Germany Magnetoencephalography Market by End-use
5.2 UK Magnetoencephalography Market
5.2.1 UK Magnetoencephalography Market by Application
5.2.1.1 UK Magnetoencephalography Market by Clinical Type
5.2.2 UK Magnetoencephalography Market by End-use
5.3 France Magnetoencephalography Market
5.3.1 France Magnetoencephalography Market by Application
5.3.1.1 France Magnetoencephalography Market by Clinical Type
5.3.2 France Magnetoencephalography Market by End-use
5.4 Russia Magnetoencephalography Market
5.4.1 Russia Magnetoencephalography Market by Application
5.4.1.1 Russia Magnetoencephalography Market by Clinical Type
5.4.2 Russia Magnetoencephalography Market by End-use
5.5 Spain Magnetoencephalography Market
5.5.1 Spain Magnetoencephalography Market by Application
5.5.1.1 Spain Magnetoencephalography Market by Clinical Type
5.5.2 Spain Magnetoencephalography Market by End-use
5.6 Italy Magnetoencephalography Market
5.6.1 Italy Magnetoencephalography Market by Application
5.6.1.1 Italy Magnetoencephalography Market by Clinical Type
5.6.2 Italy Magnetoencephalography Market by End-use
5.7 Rest of Europe Magnetoencephalography Market
5.7.1 Rest of Europe Magnetoencephalography Market by Application
5.7.1.1 Rest of Europe Magnetoencephalography Market by Clinical Type
5.7.2 Rest of Europe Magnetoencephalography Market by End-use
Chapter 6. Company Profiles
6.1 Compumedics Limited
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Regional Analysis
6.1.4 Research & Development Expenses
6.1.5 Recent strategies and developments:
6.1.5.1 Approvals and Trials:
6.1.5.2 Partnerships, Collaborations and Agreements:
6.2 Ricoh Company, Ltd
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expenses
6.3 FieldLine, Inc.
6.3.1 Company Overview
6.3.2 Recent strategies and developments:
6.3.2.1 Product Launches and Product Expansions:
6.4 MEGIN OY
6.4.1 Company Overview
6.5 CTF MEG Neuro Innovations, Inc.
6.5.1 Company Overview
6.6 Cerca Magnetics Limited
6.6.1 Company Overview
Companies Mentioned
- Compumedics Limited
- Ricoh Company, Ltd
- FieldLine, Inc.
- MEGIN OY
- CTF MEG Neuro Innovations, Inc.
- Cerca Magnetics Limited
Methodology
LOADING...
